Exclusive Summary

• Backed by top-tier US-FDA and UK-MHRA GMP certifications and an active US registration, the ICH-compliant dossier enables fast-track regulatory clearances in RoW markets via reliance pathways.
• Offers four complete dosage strengths (10mg to 40mg), perfectly matching the precise dose-titration needs for strictly first-line anti-depressant and anti-anxiety therapies recommended by global guidelines.
• Leverages a robust Chinese supply chain to deliver 'US-standard quality at Chinese manufacturing costs,' providing global distributors with highly competitive pricing power and lucrative profit margins.